Credit Agricole S A Abb Vie Inc. Transaction History

Credit Agricole S A

$9.68 Billion
Q1 2024

A detailed history of Credit Agricole S A transactions in Abb Vie Inc. stock. As of the latest transaction made, Credit Agricole S A holds 50,000 shares of ABBV stock, worth $8.36 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

50,000

Previous 86,230 42.02%

Holding current value

$8.36 Million

Previous $13.4 Million 31.86%

% of portfolio

0.09%

Previous 0.15%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$159.82 - $182.1 $7.28 Million - $8.3 Million	45,573 Added 52.85%	131,803 $24 Million
Q4 2023 Feb 13, 2024	BUY	$137.6 - $154.97 $827,526 - $931,989	6,014 Added 7.5%	86,230 $13.4 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $5.31 Million - $6.14 Million	39,714 Added 98.05%	80,216 $12 Million
Q2 2023 Jul 31, 2023	BUY	$132.51 - $164.9 $184,056 - $229,046	1,389 Added 3.55%	40,502 $5.46 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $1.76 Million - $2.03 Million	-12,185 Reduced 23.75%	39,113 $6.23 Million

Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $2.46 Million - $2.95 Million	17,761 Added 52.96%	51,298 $8.3 Million
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $576,566 - $661,283	4,296 Added 14.69%	33,537 $4.5 Million
Q2 2022 Aug 08, 2022	SELL	$137.62 - $174.96 $607,592 - $772,448	-4,415 Reduced 13.12%	29,241 $4.48 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $3.6 Million - $4.46 Million	27,263 Added 426.45%	33,656 $5.46 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $2.71 Million - $3.43 Million	-25,198 Reduced 79.76%	6,393 $865,000
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $470,500 - $534,089	4,422 Added 16.28%	31,591 $3.41 Million
Q2 2021 Aug 10, 2021	BUY	$105.21 - $117.21 $1.98 Million - $2.2 Million	18,790 Added 224.25%	27,169 $3.06 Million
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $403,368 - $444,060	-3,943 Reduced 32.0%	8,379 $907,000
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $47,730 - $64,441	-593 Reduced 4.59%	12,322 $1.32 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $374,481 - $439,517	4,359 Added 50.95%	12,915 $1.13 Million
Q2 2020 Aug 13, 2020	SELL	$73.37 - $98.18 $49,818 - $66,664	-679 Reduced 7.35%	8,556 $840,000
Q1 2020 May 14, 2020	BUY	$64.5 - $97.79 $152,994 - $231,957	2,372 Added 34.56%	9,235 $703,000
Q3 2019 Nov 08, 2019	BUY	$62.98 - $75.72 $432,231 - $519,666	6,863 New	6,863 $519,000
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $346,926 - $385,673	-3,902 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$89.78 - $106.23 $26,125 - $30,912	-291 Reduced 6.94%	3,902 $361,000
Q1 2018 May 14, 2018	SELL	$92.01 - $123.21 $5.57 Million - $7.45 Million	-60,504 Reduced 93.52%	4,193 $397,000
Q4 2017 Feb 13, 2018	SELL	$89.56 - $98.21 $105 Million - $115 Million	-1,174,645 Reduced 94.78%	64,697 $6.26 Million
Q3 2017 Nov 14, 2017	SELL	$69.85 - $89.22 $6.79 Million - $8.68 Million	-97,245 Reduced 7.28%	1,239,342 $110 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,336,587	1,336,587 $96.9 Million

Others Institutions Holding ABBV

# of Institutions

3,653

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $296B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Agricole S A, based on Form 13F filings with the SEC.

News

Stay updated on Credit Agricole S A with notifications on news.

Account

Credit Agricole S A Abb Vie Inc. Transaction History